Johnson & Johnson seeks to register vaccine
Johnson & Johnson seeks to register vaccine
THAILAND: Johnson & Johnson is seeking to register its single-shot COVID-19 vaccine in Thailand, the Food and Drug Administration (FDA) revealed yesterday (Feb 1).
Tuesday 2 February 2021, 09:08AM
Activists gather at Government House in Bangkok yesterday to demand assistance for COVID-19-affected people, especially women, children and vulnerable people. Photo: Arnun Chonmahatrakool.
The American multinational corporation has applied to register their vaccine with the FDA but some documents were missing, said Dr Surachoke Tangwiwat, deputy secretary-general of the FDA.
The company is required to have the relevant papers and file them within 30 days, he said.
25 01 2021
There’s a slang term we heard recently, when a dope was referred to as a “tool.” We had to look it up and came up with this:
Someone who others normally refer to as a prick, dick, or schmuck.
Then there’s the version that is:
A guy with a hugely over-inflated ego, who in an attempt to get undue attention for himself, will act like a jackass, because, in his deluded state, he will think it’s going to make him look cool, or make others want to be like him….
Which brings us to Veera Prateepchaikul’s latest op-ed. Veera felt the need to boil over on the vaccine crisis. Veera, along with Somchai Jitsuchon, research director for inclusive development at the Thailand Development Research Institute, both defend the vaccine deal with the king’s company, Siam Bioscience.
An adviser to the prime minister has defended the government's vaccine deal after it came under fire from critics. Somchai Jitsuchon, an adviser to Prime Minister Prayut Chan-o-cha on the economy, posted on his Facebook account that the government had considered many vaccine deal options, such as from whom it should buy, when, the quantity, or whether it should opt.
2021-01-21 15:36:01 GMT2021-01-21 23:36:01(Beijing Time) Xinhua English
BANGKOK, Jan. 21 (Xinhua) Thailand s Food and Drug Administration (FDA) has approved the registration for emergency use of COVID-19 vaccine developed by AstraZeneca, with the first shipment of 50,000 doses scheduled to arrive next month, a senior official confirmed Thursday.
The first 50,000 doses, produced by AstraZeneca in Italy, will be followed by another 150,000 doses in March and April, according to FDA Secretary General Paisal Dunkhum.
The imported AstraZeneca vaccine is yet to be certified for quality and health safety by the Department of Medical Sciences before use, Paisal said.
For the production of the AstraZeneca vaccine in Thailand by Siam Bioscience Co., the FDA chief said vaccines produced locally will not be available for use until May. Enditem